A. Boido et al. / Il Farmaco 58 (2003) 33ꢁ
/
44
43
a-benzotriazolylpropionic acids as possible antiinflammatory
agents, Chem. Abstr. 93 (1980) 239320m.
therefore, in particular situations the safety of selective
COX-2 inhibitors remains questionable [37ꢁ39].
/
[16] D. Dal Monte, A. Mangini, R. Passerini, C. Zauli, Ricerche sugli
eterocicli. Nota VI-Spettri di assorbimento nel vicino U.V. di
triazoli, benzotriazoli e fenilbenzotriazoli, Gazz. Chim. Ital. 88
(1958) 977ꢁ1034.
/
Acknowledgements
[17] G. Paglietti, F. Sparatore, Preparazione e spettri U.V. di N-
metilbenzotriazoli variamente sostituiti sul nucleo benzenico,
Financial support from the Italian ‘Ministero
dell’Universita` e della Ricerca Scientifica e Tecnologica’
is gratefully acknowledged.
Ann. Chim. 62 (1972) 128ꢁ
[18] C.K. Ingold, Structure and Mechanism in Organic Chemistry,
second ed, Cornell University Press, Ithaca, 1969, pp. 509ꢁ544.
/
143.
/
[19] P.B.D. de la Mare, B.E. Swedlund, Nucleophilic replacements of
halogens at saturated centers, in: S. Patai (Ed.), The Chemistry of
the CarbonÃ
/
Halogen Bond, Wiley, London, 1973, pp. 415ꢁ460.
/
References
[20] R. Fulwood, D. Parker, A chiral solvating agent for direct NMR
assay of the enantiomeric purity of carboxylic acids, Tetrah.
[1] F. Sparatore, F. Pagani, Alcuni acidi benzotriazolilalcanoici e
Asimm. 3 (1992) 25ꢁ28.
/
loro derivati ammidici, Farmaco, Ed. Sci. 19 (1964) 55ꢁ
[2] P. Preziosi, P. Manca, G. Paglietti, Attivita` coleretica di acidi
benzotriazolilalcanoici, Farmaco, Ed. Sci. 20 (1965) 238ꢁ247.
/75.
[21] O. Mitsunobu, The use of diethyl azodicarboxylate and triphe-
nylphosphine in synthesis and transformation of natural pro-
/
ducts, Synthesis (1981) 1ꢁ
[22] D.L. Huges, Progress in the Mitsunobu reaction. A review, Org.
Prep. Proc. Int. 28 (1996) 127ꢁ164.
/28.
[3] G. Paglietti, F. Sparatore, Preparazione di acidi b-benzotria-
zolilbutirrici variamente sostituiti quali potenziali coleretici,
/
Farmaco, Ed. Sci. 27 (1972) 380ꢁ396.
/
[23] L. Tottie, P. Baeckstrom, C. Moberg, J. Tegenfeldt, A. Heumann,
¨
[4] G. Paglietti, P. Sanna, A. Carta, F. Sparatore, I. Vazzana, A.
Peana, M. Satta, Choleretic activity of 3-[ring substituted
benzotriazol-1(2)-yl]alkanoic and alkenoic acids, Farmaco 49
Molecular sieve controlled diastereoselectivity: effect in the
palladium-catalyzed cyclization of cis-1,2-divinylcyclohexane
with a-oxygen-substituted acids as chiral nucleophiles, J. Org.
(1994) 693ꢁ702.
/
Chem. 57 (1992) 6579ꢁ6587.
/
[5] V. Picci, F. Sparatore, Effetto di acidi benzotriazolilalcanoici e di
alchilbenzotriazoli sull’accrescimento delle piante, Farmaco, Ed.
[24] S. Ferrarelli, F. Loiodice, V. Tortorella, D. Conte-Camerino,
A.M. De Luca, Carboxylic acids and skeletal muscle chloride
channel conductance: effects on the biological activity induced by
the introduction of methyl groups on the aromatic ring of chiral
Sci. 23 (1968) 131ꢁ139.
/
[6] F. Sparatore, M.I. La Rotonda, E. Ramundo, C. Silipo, A.
Vittoria, Effetto di derivati benzotriazolici sull’accrescimento
a-(4-chloro-phenoxy)alkanoic acids, Farmaco 56 (2001) 239ꢁ246.
/
delle piante, Farmaco, Ed. Sci. 33 (1978) 924ꢁ944.
/
[25] D. Dal Monte, A. Mangini, F. Montanari, Ricerche sugli
eterocicli. Nota VII-Spettri di assorbimento nel vicino U.V. di
N-ossidi della serie triazolica e basi eterocicliche, Gazz. Chim.
[7] F. Sparatore, M.I. La Rotonda, G. Caliendo, C. Silipo, A.
Vittoria, Optimization of auxine activity of benzotriazoles by
QSAR, in: J.K. Seidel (Ed.), QSAR and Strategies in the Design
of Bioactive Compounds, WCH Verlag, Weinheim, 1985, pp.
Ital. 88 (1958) 1035ꢁ1062.
/
429ꢁ
/
433.
[26] (a) F. Savelli, G. Cordella, F. Sparatore, Derivati benzo-e
[8] F. Sparatore, M.I. La Rotonda, G. Caliendo, E. Novellino, C.
Silipo, A. Vittoria, Biological data in sets of benzotriazole
derivatives active as plant growth regulators, Farmaco, Ed. Sci.
naftotriazolici quali potenziali antineoplastici, Studi Sassaresi 60
(1982) 345ꢁ348;
/
(b) F. Savelli, G. Cordella, F. Sparatore, Derivati benzo-e
naftotriazolici quali potenziali antineoplastici, Chem. Abstr. 101
(1984) 90839m.
43 (1988) 125ꢁ139.
/
[9] F. Sparatore, G. Caliendo, M.I. La Rotonda, E. Novellino, C.
Silipo, A. Vittoria, 13C-NMR and 1H-NMR chemical shifts in a
correlation analysis of benzotriazole derivatives active as plant
[27] R. Calvino, V. Mortarini, A. Serafino, Studio di alcuni derivati
del nucleo benzotriazolico, Farmaco, Ed. Sci. 35 (1980) 240ꢁ247.
/
growth regulators, Quant. Struct.-Act. Relat. 7 (1988) 178ꢁ183.
/
[28] O.L. Brady, C.V. Reynolds, Triazole compounds. Part II:
[10] J.T. Harrison, B. Lewis, P. Nelson, W. Rooks, A. Roszkowski, A.
Tomolonis, J.H. Fried, Nonsteroidal antiinflammatory agents. 6-
methylation of some 1-hydroxy-1,2,3-benzotriazoles, J. Chem.
Soc. (1928) 193ꢁ202.
/
Substituted 2-naphthylacetic acids, J. Med. Chem. 13 (1970) 203ꢁ
/
[29] W. Konig, R. Geiger, Eine neue Methode zur Synthese von
¨
205.
Peptiden: Aktivierung von Carboxyl gruppe mit Dicyclohexyl
carbodiimid unter Zusatz von 1-Hydroxybenzotriazolen, Chem.
[11] A.C. Goudie, L.M. Gaster, A.W. Lake, C.J. Rose, P.C. Freeman,
B.O. Hughes, D. Miller, 4-(6-Methoxy-2-naphtyl)butan-2-one
and related analogues, a novel structural class of antiinflamma-
Ber. 103 (1970) 788ꢁ
[30] W. Borsche, Ueber den Austauch von OR gegen andere Radikale
in Nitrophenol-athern, Chem. Ber. 56 (1923) 1488ꢁ1493.
/798.
tory compounds, J. Med. Chem. 21 (1978) 1260ꢁ1264.
/
/
¨
[12] H.A. Friedel, P.A. Todd, Nabumetone: a preliminary review of its
pharmacodynamics and pharmacokinetic properties and thera-
[31] C.A. Winter, E.A. Risley, G.W. Nuss, Carrageenin-induced
edema in hind paw of the rat as an assay for antiinflammatory
peutic efficacy in rheumatic diseases, Drugs 35 (1988) 504ꢁ524.
/
drugs, Proc. Soc. Exp. Biol. Med. 111 (1962) 544ꢁ547.
/
[13] J.S. Nicholson, Ibuprofen, in: J.S. Bindra, D. Lednicer (Eds.),
Chronicles of Drug Discovery, vol. 1, Wiley, New York, 1982, pp.
[32] R. Koster, M. Anderson, E.J. De Beer, Acetic acid for analgesic
screening, Fed. Proc. 18 (1959) 412.
[33] J.R. Vane, R.M. Botting, New insights into the mode of action of
149ꢁ172.
/
[14] A. Marzo, G. Quadro, G. Bruno, E. Treffner, F.L. Reali, G.
Borrelli, R. Stradi, MR714, a new aryloxypropionic non-steroidal
anti-inflammatory drugs, Inflam. Res. 44 (1995) 1ꢁ
[34] J.J. Talley, Selective inhibitors of cyclooxygenase-2 (COX-2),
Progr. Med. Chem. 36 (1999) 201ꢁ234.
[35] G. Dannhardt, W. Kiefer, Cyclooxygenase inhibitors*
status and future prospects, Eur. J. Med. Chem. 36 (2001) 109ꢁ
126.
/10.
antiinflammatory agent, Arzneim. Forsch. 33 (1983) 198ꢁ205.
[15] (a) A. Boido, I. Vazzana, F. Sparatore, Benzotriazolylacetic and
a-benzotriazolylpropionic acids as possible antiinflammatory
/
/
/
current
/
agents, Studi Sassaresi 57 (1979) 787ꢁ800;
(b) A. Boido, I. Vazzana, F. Sparatore, Benzotriazolylacetic and
/